Monte Rosa Therapeutics, Inc. GLUE Defined Benefit Pension Plan Liabilities (Non-Current)
Defined Benefit Pension Plan Liabilities (Non-Current) at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s defined benefit pension plan liabilities (non-current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s defined benefit pension plan liabilities (non-current)?
- Monte Rosa Therapeutics, Inc. (GLUE) reported defined benefit pension plan liabilities (non-current) of $5.26M in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s defined benefit pension plan liabilities (non-current) changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s defined benefit pension plan liabilities (non-current) increased by 32.8% year-over-year, from $3.96M to $5.26M.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s defined benefit pension plan liabilities (non-current)?
- Over 5 years (2020 to 2025), Monte Rosa Therapeutics, Inc.'s defined benefit pension plan liabilities (non-current) has grown at a 37.6% compound annual growth rate (CAGR), from $1.07M to $5.27M.
- What does defined benefit pension plan liabilities (non-current) mean?
- This represents the long-term shortfall between the projected benefit obligations of a company's pension plans and the fair value of the plan assets. It reflects the company's long-term commitment to provide retirement benefits to employees. A significant liability indicates a potential future cash requirement to fund the pension plan.